Target intelligence / Profile preview

Melanosome transfer machinery

Molecular classification
Protein complex, Transport system, Receptor (PAR-2 component), GTPase (Rab27a component), Motor protein (Myosin Va component)
01

Overview

The melanosome transfer machinery is a complex multi-protein system responsible for the movement of melanin-containing organelles (melanosomes) from melanocytes to neighboring keratinocytes in the skin and hair follicles (PMID: 33075361, 36142345). This process is essential for visible pigmentation and photoprotection, as it allows for the distribution of melanin throughout the epidermis to protect keratinocyte nuclei from UV-induced DNA damage (PMID: 25104162). The machinery involves several distinct stages: intracellular transport within melanocytes mediated by the Rab27a-Melanophilin-Myosin Va ternary complex, dendrite extension regulated by Rho GTPases like Cdc42, and intercellular transfer to keratinocytes, which is significantly regulated by the Protease-activated receptor 2 (PAR-2) (PMID: 33075361, 10702237). Dysregulation of this machinery is linked to various pigmentary disorders, including hyperpigmentation (e.g., melasma, post-inflammatory hyperpigmentation) and rare genetic conditions like Griscelli syndrome, which is caused by mutations in core components like Rab27a or Myosin Va (PMID: 11017072). Therapeutic targeting of the melanosome transfer machinery, such as through PAR-2 antagonists or agents like niacinamide that block transfer, provides a strategy for managing skin pigmentation without necessarily inhibiting the enzymatic synthesis of melanin itself (PMID: 12100180, 10702237).

Other names
Melanosome transport systemMelanocyte-keratinocyte transfer complexMelanin transfer machineryMelanosome transport and transfer machinery
02

Mechanism of action

Inhibition of melanosome transport within melanocytes (e.g., disruption of the Rab27a-MLPH-MyoVa complex) and suppression of melanosome uptake by keratinocytes (e.g., antagonism of PAR-2 or inhibition of phagocytosis).

03

Biological functions

PigmentationIntracellular organelle transportExocytosisPhagocytosisPhotoprotection
04

Disease associations

HyperpigmentationMelasmaVitiligoGriscelli syndromePost-inflammatory hyperpigmentationChediak-Higashi syndrome
05

Safety considerations

Hypopigmentation (leukoderma)Skin irritationPotential systemic effects if targeting conserved intracellular transport proteinsReduced photoprotection against UV radiation
06

Interacting drugs

Niacinamide

6 more in the full profile.

07

Biomarkers

Melanin content/indexProtease-activated receptor 2 (PAR-2) expression levelsRab27a protein levelsMelanophilin (MLPH) expressionMelanocyte dendrite length and number

Beyond the preview

Go deeper on Melanosome transfer machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanosome transfer machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call